Daily non-political popular news in brief.
Treating prostate cancer in elderly men associated with longer survival, compared to non-treatment
12-12-2006 · EurekAlert!New findings from an observational study suggest that elderly men who received treatment for localized prostate cancer survived significantly longer than men who did not receive treatment, according to a study in the December 13 issue of JAMA; however, the investigators emphasize the importance of validating these results in randomized trials.
Read more »
Keywords: treating, prostate, cancer, elderly, men, associated, longer, survival, compared, non-treatment, non, treatment
« Previous | Next »
Similar news on "Treating prostate cancer in elderly men associated with longer survival, compared to non-treatment":
- Analysis: Older men treated for early prostate cancer live longer than those not treated
12-12-2006 · EurekAlert!
An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
Similar news · Read more »
- Phase II study shows HRPC patients with bone metastases see improved survival with ZD4054
09-25-2007 · EurekAlert!
New Phase II data presented today suggest that ZD4054, a novel compound in development for the treatment of men with hormone-resistant prostate cancer, could offer a promising improvement in overall survival in men with metastatic HRPC who were asymptomatic or mildly symptomatic for pain.1 Patients who received ZD4054 10mg once-daily experienced a 45 percent reduction in the risk of death compared to placebo.
Similar news · Read more »
- Adding radiation therapy for treatment of advanced prostate cancer may offer benefit
11-14-2006 · EurekAlert!
Treating advanced prostate cancer with radiation therapy after removal of the prostate gland reduces the risk of disease recurrence, but does not appear to significantly improve the length of survival, according to a study in the Nov. 15 issue of JAMA, a theme issue on men's health.
Similar news · Read more »
- Analysis: Older men treated for early prostate cancer
12-12-2006 · EurekAlert!
An analysis of Surveillance, Epidemiology and End Results-Medicare records for 44,630 older men suggests surgery or radiation therapy for early-stage prostate cancer increased the lifespan of men between 65 and 80 years old compared to observation, sometimes known as "watch and wait." The study supported a benefit of treatment even for men whose disease had a low risk of spreading, and even if they were elderly men (75 to 80 years old).
Similar news · Read more »
- Additional hormone therapy use after radiation for some prostate cancers extends survival
11-06-2006 · EurekAlert!
The largest study examining the benefits of long-term use of hormone therapy after radiation treatment for prostate cancer shows men with aggressive locally advanced disease live longer if hormones are used for an additional 24 months. Research also showed other significant benefits for those with less aggressive cancers who receive hormones.
Similar news · Read more »
- Combination therapy improves survival for certain prostate cancer patients
01-22-2008 · EurekAlert!
Men with localized prostate cancer who were treated with male hormone suppression therapy and radiation treatment had longer survival, but those with moderate to high levels of other illnesses did not experience this effect, according to a study in the Jan. 23 issue of JAMA.
Similar news · Read more »
- Study first: Over-expression of Cox-2 can predict prostate cancer outcome
11-08-2006 · EurekAlert!
Researchers say an over-expression of COX-2 in men with prostate cancer is associated with an increase in PSA after radiation treatment and the spread of the cancer outside of the prostate. That is the result of the first study linking COX-2 with prostate cancer radiation treatment outcomes.
Similar news · Read more »
- Rhode Island Hospital study confirms RF ablation effective for treating inoperable lung cancer
03-27-2007 · EurekAlert!
The overall results of a study of 153 patients with inoperable lung cancer show RF ablation to be safe and linked it with promising long-term survival and local tumor progression outcomes when compared to the older treatment method of external beam radiation (EBT). The study appears in the April issue of the journal Radiology.
Similar news · Read more »
- Survival data presented from phase II study of hormone-resistant prostate cancer patients
09-25-2007 · EurekAlert!
The results from a randomized, double-blind, placebo-controlled, Phase II study of ZD4054 -- a specific endothelin A receptor antagonist -- were delivered today at the 14th European Congress of Clinical Oncology (ECCO, 23-27 Sept., Barcelona). The data presented today for ZD4054, an investigational compound in development for the treatment of men with hormone-resistant prostate cancer, showed no differences in progression-free survival but did report encouraging overall survival data.
Similar news · Read more »
- Largest study to evaluate PSA 'bounce' shows overall survival is not affected
11-08-2006 · EurekAlert!
A study involving more than 7,500 men with prostate cancer treated with radiation concludes that a rise in the PSA level after treatment -- called PSA bounce -- does not have clinical relevance and does not affect survival. The results of this multi-institutional study will be presented today.
Similar news · Read more »
